Solas Capital Management, LLC Fennec Pharmaceuticals Inc. Transaction History

Solas Capital Management, LLC

$125 Million
Q3 2024

A detailed history of Solas Capital Management, LLC transactions in Fennec Pharmaceuticals Inc. stock. As of the latest transaction made, Solas Capital Management, LLC holds 1,923,536 shares of FENC stock, worth $7.67 Million. This represents 7.68% of its overall portfolio holdings.

Number of Shares

1,923,536

Previous 1,340,000 43.55%

Holding current value

$7.67 Million

Previous $8.19 Million 17.47%

% of portfolio

7.68%

Previous 4.92%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$4.85 - $6.73 $2.83 Million - $3.93 Million	583,536 Added 43.55%	1,923,536 $9.62 Million
Q2 2024 Aug 14, 2024	BUY	$6.02 - $10.99 $1.38 Million - $2.53 Million	229,767 Added 20.7%	1,340,000 $8.19 Million
Q1 2024 May 15, 2024	SELL	$8.82 - $11.12 $2.37 Million - $2.98 Million	-268,280 Reduced 19.46%	1,110,233 $12.3 Million
Q4 2023 Feb 14, 2024	SELL	$6.48 - $11.61 $2.25 Million - $4.03 Million	-347,054 Reduced 20.11%	1,378,513 $15.5 Million
Q3 2023 Nov 14, 2023	BUY	$7.15 - $8.94 $2.05 Million - $2.56 Million	286,539 Added 19.91%	1,725,567 $13 Million
Q2 2023 Aug 14, 2023	BUY	$7.27 - $9.82 $1.12 Million - $1.52 Million	154,485 Added 12.03%	1,439,028 $12.7 Million
Q1 2023 May 15, 2023	BUY	$7.38 - $10.35 $237,303 - $332,804	32,155 Added 2.57%	1,284,543 $10.7 Million
Q4 2022 Feb 14, 2023	BUY	$7.63 - $10.22 $924,916 - $1.24 Million	121,221 Added 10.72%	1,252,388 $12 Million
Q3 2022 Nov 14, 2022	SELL	$5.71 - $8.54 $241,812 - $361,660	-42,349 Reduced 3.61%	1,131,167 $9.16 Million
Q2 2022 Aug 15, 2022	BUY	$5.17 - $6.33 $143,312 - $175,467	27,720 Added 2.42%	1,173,516 $6.55 Million
Q1 2022 May 16, 2022	BUY	$4.29 - $6.08 $1.19 Million - $1.69 Million	277,939 Added 32.03%	1,145,796 $6.42 Million
Q2 2021 Aug 16, 2021	BUY	$5.96 - $7.85 $404,427 - $532,677	67,857 Added 8.48%	867,857 $6.33 Million
Q3 2020 Nov 16, 2020	SELL	$5.19 - $10.17 $830,400 - $1.63 Million	-160,000 Reduced 16.67%	800,000 $4.85 Million
Q1 2020 May 15, 2020	SELL	$4.89 - $8.1 $57,677 - $95,539	-11,795 Reduced 1.21%	960,000 $5.7 Million
Q4 2019 Feb 14, 2020	BUY	$4.25 - $6.49 $121,528 - $185,581	28,595 Added 3.03%	971,795 $6.31 Million
Q3 2019 Nov 14, 2019	BUY	$3.85 - $4.95 $358,900 - $461,443	93,221 Added 10.97%	943,200 $4.54 Million
Q2 2019 Aug 14, 2019	BUY	$3.3 - $5.09 $2.8 Million - $4.33 Million	849,979 New	849,979 $3.4 Million

Others Institutions Holding FENC

# of Institutions

Shares Held

14.9M

Call Options Held

10K

Put Options Held

83.8K

View Full List

About FENNEC PHARMACEUTICALS INC.

Ticker FENC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,067,300
Market Cap $104M
Description
Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. Its product candidate in the clinical stage of development is PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec...

More about FENC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Solas Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Solas Capital Management, LLC with notifications on news.

Account

Solas Capital Management, LLC Fennec Pharmaceuticals Inc. Transaction History